HOME >> BIOLOGY >> NEWS
False Security: You Can't Always Believe The Results Of A Genetic Test

Many laboratories offering genetic tests for cystic fibrosis don't test for enough mutations to give reliable results, according to a new study.

Last year, a panel convened by the US National Institutes of Health (NIH) recommended that prospective parents be routinely offered tests to see if they carry mutations that could give their children cystic fibrosis. This was the first time a genetic test had been recommended for the general population (This Week, 26 April 1997, p 12). The new findings, from a team of geneticists led by Wayne Grody of the University of California at Los Angeles, suggest that this recommendation was premature.

Cystic fibrosis, in which the lungs and airways become clogged with mucus and prone to infections, is caused by defects in a single large gene. There are hundreds of these mutations. Some are very rare, and certain mutations are more common in particular ethnic groups.

To be effective, the widespread screening urged by the NIH panel would have to test for many of the most common mutations. Exactly how many is still a matter of debate. "One thing that was conspicuously lacking from the panel's recommendation was how many mutations should be tested for," says Grody, who is co-chair of a committee drawing up guidelines on the issue for the American College of Medical Genetics (ACMG). To identify 90 per cent or more of people carrying cystic fibrosis genes, it may be necessary to test for 20 of the most common mutations, Grody predicts.

Grody also leads a team of geneticists monitoring the testing labs on behalf of the ACMG and the College of American Pathologists. The team's latest survey, published in The American Journal of Human Genetics (vol 62, p 1252), reveals a disturbing picture. The investigators asked 45 labs how many mutations in the cystic fibrosis gene they usually test for. Forty-three responded, reporting numbers ranging from just one to 70. It was most co
'"/>

Contact: Claire Bowles
Claire Bowles@rbi.co.uk
01 71 331-2751
New Scientist
20-May-1998


Page: 1 2

Related biology news :

1. Cant stand the pain? Your genes may be to blame
2. If You Cant Stop Polluting, Try Changing The Weather Instead
3. As A Carbon Sponge, Iron-Poor Coastal Waters Cant Always Do The Job, NaturePaper Shows
4. The Commons: Not Always A Tragedy
5. Once A Bully, Always A Bully, Invasive Non-Native Plants Tend To Be Aggressive Wherever They Find Themselves
6. Chemical Reaction Believed To Support Underground Microbes Is Now Unlikely
7. Results of pivotal study for GlaxoSmithKlines Valtrex published in New England Journal of Medicine
8. Results from open-label Raptiva study suggest continued benefit with long-term treatment
9. NASA Materials Conference Features Science Results, Experts on Technologies for Exploration
10. Abgenix Reports Encouraging Preclinical Results With ABX-EGF In Cancer Research
11. Encouraging Results In Preclinical Studies Of Parkinsons Disease Gene Therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/1/2020)... Conn. (PRWEB) , ... May 01, 2020 , ... More ... Neag Comprehensive Cancer Center’s High-Risk Cancer Program, which is led by two genetic counselors. ... counseling solutions, today announced it is teaming up with UConn’s High Rick Program to ...
(Date:4/30/2020)... ... April 28, 2020 , ... Ever a ... effort in providing timely and critical information to life science organizations as they ... health safety concerns. , “Providing the most up-to-date actionable guidance and information has ...
(Date:4/28/2020)... FT. LAUDERDALE, Fla. (PRWEB) , ... April 27, ... ... official launch. The first-of-its-kind category-defining service was started by three teenagers with an ... a change in the world during the time of great need and suffering, ...
Breaking Biology News(10 mins):
(Date:4/22/2020)... ... April 20, 2020 , ... Global molecular diagnostics ... that Omixon’s founder and chairman Dr. Attila Berces returns as CEO. Outgoing CEO ... since 2014 before stepping into the CEO role in 2017. , In ...
(Date:4/22/2020)... ... April 21, 2020 , ... Ripple Science today announced new ... teams are working remotely and have paused patient visits, forcing teams to do ... research during this uncertain time by giving research teams free access to Ripple ...
(Date:4/7/2020)... , ... April 06, 2020 , ... Gateway Genomics ... children, reached 200,000 SneakPeek Early Gender DNA Tests sold in March, just ... was launched as an ecommerce product, where a mom could order her kit online, ...
(Date:4/1/2020)... Ky. (PRWEB) , ... March 30, 2020 , ... ... launch of its latest product, ArmourGuard® RTU, an EPA-approved spray-on antimicrobial solution. As ... only biosecurity solution that provides continual antimicrobial activity against microorganisms for up to ...
Breaking Biology Technology:
Cached News: